Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
October 5, 2017
Design, synthesis and biological evaluation of WZ4002 analogues as EGFR inhibitors
Aireen A Romu, Zining Lei, Bin Zhou, et al.
Drug Discovery Today
|
May 24, 2021
Recent progress on targeting leukemia stem cells
Xiang-Yu Ma, Liuya Wei, Zining Lei, et al.
Cancer Letters
|
November 5, 2018
Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo
Albert A De Vera, Pranav Gupta, Zining Lei, et al.
Frontiers in Bioscience (Landmark Edition)
|
January 29, 2022
ABCB1 limits the cytotoxic activity of TAK-243, an inhibitor of the ubiquitin-activating enzyme UBA1
Zhuoxun Wu, Yuqi Yang, Zining Lei, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Bioorganic & Medicinal Chemistry Letters
|
October 5, 2017
Design, synthesis and biological evaluation of WZ4002 analogues as EGFR inhibitors
Aireen A Romu, Zining Lei, Bin Zhou, et al.
Drug Discovery Today
|
May 24, 2021
Recent progress on targeting leukemia stem cells
Xiang-Yu Ma, Liuya Wei, Zining Lei, et al.
Cancer Letters
|
November 5, 2018
Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo
Albert A De Vera, Pranav Gupta, Zining Lei, et al.
Frontiers in Bioscience (Landmark Edition)
|
January 29, 2022
ABCB1 limits the cytotoxic activity of TAK-243, an inhibitor of the ubiquitin-activating enzyme UBA1
Zhuoxun Wu, Yuqi Yang, Zining Lei, et al.
Page
of 1